Evaluating Commercial Anti-Plaque Products and Oral Rinse

Launched by COLGATE PALMOLIVE · Oct 5, 2009

Keywords

ClinConnect Summary

This clinical research study was to train new examiners for short term plaque clinical methodologies.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female volunteers at least 18 years of age.
• • Good general health.
• • Must sign informed consent form.
• • Minimum of 20 natural uncrowned teeth (excluding third molars) must be present.
• • No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.
• Exclusion Criteria:
• • Subjects unable or unwilling to sign the informed consent form.
• • Medical condition which requires pre-medication prior to dental visits/procedures.
• • Moderate or advanced periodontal disease or heavy dental tartar (calculus).
• • Two or more decayed untreated dental sites at screening.
• • Other disease of the hard or soft oral tissues.
• • Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).
• • Use of medications that are currently affect salivary function.
• • Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1.
• • Allergy to chlorhexidine.
• • Pregnant or nursing women.
• • Participation in any other clinical study within 1 week prior to enrollment into this study.
• • Use of tobacco products.
• • Subjects who must receive dental treatment during the study dates.
• • Current use of Antibiotics for pre-medication for dental treatment or for any other purpose.
• • Presence of an orthodontic appliance that interferes with plaque scoring.
• • History of allergy to common dentifrice ingredients.
• • Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy).